Declaration of results of remote e-voting and e-voting conducted during AGM held on Tuesday , 30th September 2025 along with the scrutiniser report under regulation 44 of SEBI(Listing Obligations ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd held its 32nd Annual General Meeting on Tuesday, 30 September 2025 via video conferencing. The company had 12,681 shareholders on the record date, with 42 shareholders attending via VC (1 promoter group representative and 41 public shareholders). Out of 4,73,12,741 total outstanding shares, 3,55,22,186 votes (about 75.08%) were cast through remote e-voting and e-voting at the AGM. All five resolutions were passed with overwhelming majority: adoption of audited financial statements for FY ended 31 March 2025, re-appointment of Sameer Goel as director (retires by rotation), appointment of Neeraj Arora & Associates as statutory auditors until the 37th AGM, approval of cost auditor remuneration for FY 2025-26, and appointment of Harish Kumar as secretarial auditor. Each resolution received over 99.99% votes in favour, with only 2,997 votes (0.007%) against resolutions 2-5. Ms. Isha Bothra acted as scrutinizer and submitted her report on 2 October 2025.
This is a routine post-AGM compliance filing confirming that all agenda items were approved by shareholders with near-unanimous support. The 75% voting turnout shows healthy shareholder engagement. No material surprises or contentious issues — minor governance note is that the scrutinizer was appointed on the same day as the AGM after the previous one resigned, but the process was completed in a fair and transparent manner. No expected share price impact.